Deep Genomics
AI-powered drug discovery
2 open rolesAI-powered drug discoveryToronto, Canada106 employees$238M raisedEst. 2014
Khosla Ventures
SoftBank Vision Fund 2
Canadian Pension Plan Investment Board (CPP Investments)
Fidelity Management & Research Company LLC
Alexandria Venture Investments
Amplitude Ventures
About Deep Genomics
- Deep Genomics develops an artificial intelligence-powered discovery platform that untangles the complexity in RNA biology.
- The platform identifies novel targets and evaluates thousands of possibilities to support geneticists, molecular biologists, chemists, toxicologists, and drug developers in the identification and development of genetic medicines.
Deep Genomics is listed on Rocketlist with 2 active roles. The company is categorized as AI-powered drug discovery in BioTech. Deep Genomics is at Series C stage, with a B2B business model, headquartered in Toronto, Canada. Deep Genomics was founded in 2014 and has 106 employees. Deep Genomics has raised $238M. Active roles are refreshed daily from public hiring sources.